![Sungjin Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sungjin Kim
Plus aucun poste en cours
Profil
Sungjin Kim is the founder of Indapta Therapeutics, Inc. which was founded in 2017.
Anciens postes connus de Sungjin Kim
Sociétés | Poste | Fin |
---|---|---|
Indapta Therapeutics, Inc.
![]() Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Indapta Therapeutics, Inc.
![]() Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Health Technology |